Tissue-engineered devices in cardiovascular surgery

European Surgical Research

Volumn 49, Issue 1, 2012, Pages 44-52

  Klopsch, C ^a   Steinhoff, G ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Antigenicity; Artificial and biological prostheses; Decellularized graft; Endothelialization; In vitro and in vivo cellularization; Vascularization

Indexed keywords

POLITEF; POLYCAPROLACTONE; POLYGLYCOLIC ACID; POLYLACTIDE; POLYMER;

ANTIGENICITY; CARDIOMYOPLASTY; CARDIOVASCULAR EQUIPMENT; CARDIOVASCULAR SURGERY; CELL SURVIVAL; HEART; HEART GRAFT; HEART MUSCLE CELL; HEART TRANSPLANTATION; HEART VALVE; HEART VALVE BIOPROSTHESIS; HEMODIALYSIS; HUMAN; HYPERPLASIA; IN VITRO STUDY; IN VIVO STUDY; MICROENVIRONMENT; NONHUMAN; POLITEF IMPLANT; PRIORITY JOURNAL; REVIEW; SMALL INTESTINE MUCOSA; THROMBOGENICITY; TISSUE ENGINEERING;

ANIMALS; BIOPROSTHESIS; CARDIAC SURGICAL PROCEDURES; ENDOTHELIUM, VASCULAR; HUMANS; TISSUE ENGINEERING; VASCULAR SURGICAL PROCEDURES;

EID: 84863876461     PISSN: 0014312X     EISSN: 14219921     Source Type: Journal    
DOI: 10.1159/000339606     Document Type: Review

References (77)

1. Klopsch C, Donndorf P, Kaminski A, Ma N, Steinhoff G: Cell sources for cardiovascular tissue engineering. Chirurg 2011; 82: 295-302.
2. Mayer JE Jr: In search of the ideal valve replacement device. J Thorac Cardiovasc Surg 2001; 122:8-9.
3. Tan MY, Zhi W, Wei RQ, Huang YC, Zhou KP, Tan B, Deng L, Luo JC, Li XQ, Xie HQ, Yang ZM: Repair of infarcted myocardium using mesenchymal stem cell seeded small intestinal submucosa in rabbits. Biomateri-als 2009; 30:3234-3240.
4. Lutter G, Metzner A, Jahnke T, Bombien R Boldt J, Iino K, Cremer J, Stock UA: Percutaneous tissue-engineered pulmonary valved stent implantation. Ann Thorac Surg 2010; 89:259-263.
5. Herring M, Gardner A, Glover J: Seeding en-dothelium onto canine arterial prostheses. The effects of graft design. Arch Surg 1979; 114:679-682.
6. Graham LM, Burkel WE, Ford JW, Vinter DW, Kahn RH, Stanley JC: Expanded polytetrafluoroethylene vascular prostheses seeded with enzymatically derived and cultured canine endothelial cells. Surgery 1982; 91:550-559.
7. Riha GM, Lin PH, Lumsden AB, Yao Q, Chen C: Review: application of stem cells for vascular tissue engineering. Tissue Eng 2005; 11:1535-1552.
8. Bölgen N, Menceloglu YZ, Acatay K, Vargel I, Piskin E: In vitro and in vivo degradation of non-woven materials made of poly(epsilon-caprolactone) nanofibers prepared by elec-trospinning under different conditions. J Biomater Sci Polym Ed 2005; 16: 1537-1555.
9. Gaumer J, Prasad A, Lee D, Lannutti J: Structure-function relationships and source-to-ground distance in electrospun polycapro-lactone. Acta Biomater 2009; 5:1552-1561.
10. Nottelet B, Pektok E, Mandracchia D, Tille JC, Walpoth B, Gurny R, Möller M: Factorial design optimization and in vivo feasibility of poly(epsilon-caprolactone)-micro-and nano-fiber-based small diameter vascular grafts. J Biomed Mater Res A 2009; 89:865-875.
11. Wang S, Yaszemski MJ, Gruetzmacher JA, Lu L: Photo-crosslinked poly(?-caprolactone fumarate) networks: roles of crystallinity and crosslinking density in determining me-chanical properties. Polymer (Guildf) 2008; 49:5692-5699.
12. Sant S, Khademhosseini A: Fabrication and characterization of tough elastomeric fibrous scaffolds for tissue engineering applications. Conf Proc IEEE Eng Med Biol Soc 2010; 2010: 3546-3548.
13. Baker BM, Nerurkar NL, Burdick JA, Elliott DM, Mauck RL: Fabrication and modeling of dynamic multipolymer nanofibrous scaffolds. J Biomech Eng 2009; 131: 101012.
14. Peroglio M, Gremillard L, Gauthier C, Chazeau L, Verrier S, Alini M, Chevalier J: Mechanical properties and cytocompatibil-ity of poly(?-caprolactone)-infiltrated bi-phasic calcium phosphate scaffolds with bi-modal pore distribution. Acta Biomater 2010; 6:4369-4379.
15. Sarkar S, Isenberg BC, Hodis E, Leach JB, Desai TA, Wong JY: Fabrication of alayered microstructured polycaprolactone construct for 3-D tissue engineering. J Biomater Sci Polym Ed 2008; 19: 1347-1362.
16. Koch S, Flanagan TC, Sachweh JS, Tanios F, Schnoering H, Deichmann T, Ellä V, Kel-lomäki M, Gronloh N, Gries T, Tolba R Schmitz-Rode T, Jockenhoevel S: Fibrin-polylactide-based tissue-engineered vascular graft in the arterial circulation. Biomate-rials 2010; 31:4731-4739.
17. Eshraghi S, Das S: Mechanical and micro-structural properties of polycaprolactone scaffolds with one-dimensional, two-dimensional, and three-dimensional orthogonally oriented porous architectures produced by selective laser sintering. Acta Biomater 2010; 6: 2467-2476.
18. Lebourg M, Sabater Serra R, Más Estellés J, Hernández Sánchez F, Gómez Ribelles JL, Suay Antón J: Biodegradable polycaprolactone scaffold with controlled porosity obtained by modified particle-leaching technique. J Mater Sci Mater Med 2008; 19: 2047-2053.
19. Soliman S, Sant S, Nichol JW, Khabiry M, Traversa E, Khademhosseini A: Controlling the porosity of fibrous scaffolds by modulating the fiber diameter and packing density. J Biomed Mater Res A 2011; 96: 566-574.
20. Cicha I, Rüffer A, Cesnjevar R, Glöckler M, Agaimy A, Daniel WG, Garlichs CD, Dit-trich S: Early obstruction of decellularized xenogenic valves in pediatric patients: involvement of inflammatory and fibroprolif-erative processes. Cardiovasc Pathol 2011; 20:222-231.
21. Daly KA, Stewart-Akers AM, Hara H, Ezze-larab M, Long C, Cordero K, Johnson SA, Ayares D, Cooper DK, Badylak SF: Effect of the alphaGal epitope on the response to small intestinal submucosa extracellular matrix in a nonhuman primate model. Tissue Eng Part A 2009; 15: 3877-3888.
22. van der Giessen WJ, Lincoff AM, Schwartz RS, van Beusekom HM, Serruys PW, Holmes DR Jr, Ellis SG, Topol EJ: Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 1996; 94: 1690-1697.
23. Rieder E, Kasimir MT, Silberhumer G, See-bacher G, Wolner E, Simon P, Weigel G: De-cellularization protocols of porcine heart valves differ importantly in efficiency of cell removal and susceptibility of the matrix to recellularization with human vascular cells. J Thorac Cardiovasc Surg 2004; 127: 399-405.
24. Kasimir MT, Rieder E, Seebacher G, Wolner E, Weigel G, Simon P: Presence and elimination of the xenoantigen gal (alpha1, 3) gal in tissue-engineered heart valves. Tissue Eng 2005; 11:1274-1280.
25. Kasimir MT, Weigel G, Sharma J, Rieder E, Seebacher G, Wolner E, Simon P: The decel-lularized porcine heart valve matrix in tissue engineering: platelet adhesion and activation. Thromb Haemost 2005; 94: 562-567.
26. Bader A, Schilling T, Teebken OE, Brandes G, Herden T, Steinhoff G, Haverich A: Tissue engineering of heart valves-Human endo-thelial cell seeding of detergent acellularized porcine valves. Eur J Cardiothorac Surg 1998; 14: 279-284.
27. Bader A, Steinhoff G, Strobl K, Schilling T, Brandes G, Mertsching H, Tsikas D, Froelich J, Haverich A: Engineering of human vascular aortic tissue based on a xenogeneic starter matrix. Transplantation 2000; 70:7-14.
28. Walluscheck K P, Steinhoff G, Haverich A: Endothelial cell seeding of native vascular surfaces. Eur J Vasc Endovasc Surg 1996; 11: 290-303.
29. Walluscheck KP, Steinhoff G, Kelm S, Hav-erich A: Improved endothelial cell attachment on ePTFE vascular grafts pretreated with synthetic RGD-containing peptides. Eur J Vasc Endovasc Surg 1996; 12:321-330.
30. Kaminski A, Klopsch C, Mark P, Yerebakan C, Donndorf P, Gäbel R, Eisert F, Hasken S, Kreitz S, Jockenhövel S, Ma N, Liebold A, Steinhoff G: Autologous valve replacement-CD133+ stem cell-plus-fibrin composite based sprayed cell seeding for intra-opera-tive heart valve tissue engineering. Tissue Eng Part C 2011; 17:299-309.
31. Flanagan TC, Sachweh JS, Frese J, Schnoring H, Gronloh N, Koch S, Tolba RH, Schmitz-Rode T, Jockenhoevel S: In vivo remodeling and structural characterization of fibrin-based tissue-engineered heart valves in the adult sheep model. Tissue Eng Part A 2009; 15:2965-2976.
32. Ko IK, Ju YM, Chen T, Atala A, Yoo JJ, Lee SJ: Combined systemic and local delivery of stem cell inducing/recruiting factors for in situ tissue regeneration. FASEB J 2012; 26: 158-168.
33. Steinhoff G, Stock U, Karim N, Mertsching H, Timke A, Meliss RR, Pethig K, Haverich A, Bader A: Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits: in vivo restoration of valve tissue. Circulation 2000; 102:III50-III55.
34. Walpoth BH, Möller M: Tissue engineering of vascu lar prostheses. Chirurg 2011; 82: 303-310.
35. Innocente F, Mandracchia D, Pektok E, Not-telet B, Tille JC, de Valence S, Faggian G, Mazzucco A, Kalangos A, Gurny R, Moeller M, Walpoth BH: Paclitaxel-eluting biodegradable synthetic vascular prostheses: a step towards reduction of neointima formation? Circulation 2009; 120:S37-S45.
36. Niklason LE, Gao J, Abbott WM, Hirschi KK, Houser S, Marini R, Langer R: Functional arteries grown in vitro. Science 1999; 284: 489-493.
37. Teebken OE, Bader A, Steinhoff G, Haverich A: Tissue engineering of vascular grafts: human cell seeding of decellularised porcine matrix. Eur J Vasc Endovasc Surg 2000; 19: 381-386.
38. Shin'oka T, Imai Y, Ikada Y: Transplantation of a tissue-engineered pulmonary artery. N Engl J Med 2001; 344: 532-533.
39. McAllister TN, Maruszewski M, Garrido SA, Wystrychowski W, Dusserre N, Marini A, Zagalski K, Fiorillo A, Avila H, Manglano X, Antonelli J, Kocher A, Zembala M, Cier-pka L, de la Fuente LM, L'heureux N: Effectiveness of haemodialysis access with an au-tologous tissue-engineered vascular graft: a multicentre cohort study. Lancet 2009; 373: 1440-1446.
40. Sobral JM, Caridade SG, Sousa RA, Mano JF, Reis RL: Three-dimensional plotted scaffolds with controlled pore size gradients: effect of sca f fold geometry on mecha nical performance and cell seeding efficiency. Acta Biomater 2011; 7:1009-1018.
41. Pektok E, Nottelet B, Tille JC, Gurny R, Ka-langos A, Moeller M, Walpoth BH: Degradation and healing characteristics of small-diameter poly(epsilon-caprolactone) vascular grafts in the rat systemic arterial circulation. Circulation 2008; 118: 2563-2570.
42. Hibino N, McGillicuddy E, Matsumura G, Ichihara Y, Naito Y, Breuer C, Shinoka T: Late-term results of tissue-engineered vascular grafts in humans. J Thorac Cardiovasc Surg 2010; 139: 431-436.
43. Brown JW, Ruzmetov M, Rodefeld MD, Vijay P, Turrentine MW: Right ventricular outf low tract reconstruction with an allograft conduit in non-Ross patients: risk factors for al-lograft dysfunction and failure. Ann Thorac Surg 2005; 80:655-663.
44. Frigiola A, Varrica A, Satriano A, Giamberti A, Pomè G, Abella R, Carminati M, Carlucci C, Ranucci M, Surgical and Clinical Outcome REsearch (SCORE) Group: Neoaortic valve and root complex evolution after ross operation in infants, children, and adolescents. Ann Thorac Surg 2010; 90: 1278-1285.
45. Cebotari S, Lichtenberg A, Tudorache I, Hil-fiker A, Mertsching H, Leyh R, Breymann T, Kallenbach K, Maniuc L, Batrinac A, Repin O, Maliga O, Ciubotaru A, Haverich A: Clinical application of tissue engineered human heart valves using autologous progenitor cells. Circulation 2006; 114:I132-I137.
46. Del Gaudio C, Bianco A, Grigioni M: Elec-trospun bioresorbable trileaflet heart valve prosthesis for tissue engineering: in vitro functional assessment of a pulmonary cardiac valve design. Ann Ist Super Sanita 2008,44: 178-186.
47. Weston MW, Yoganathan AP: Biosynthetic activity in heart valve leaflets in response to in vitro flow environments. Ann Biomed Eng 2001; 29: 752-763.
48. Engelmayr GC Jr, Rabkin E, Sutherland FW, Schoen FJ, Mayer JE Jr, Sacks MS: The independent role of cyclic flexure in the early in vitro development of an engineered heart valve tissue. Biomaterials 2005; 26: 175-187.
49. Wang Q, McGoron AJ, Bianco R, Kato Y, Pinchuk L, Schoephoerster RT: In-vivo assessment of a novel polymer (SIBS) trileaflet heart valve. J Heart Va lve Dis 2010; 19: 499-505.
50. Brown JW, Elkins RC, Clarke DR, Tweddell JS, Huddleston CB, Doty JR, Fehrenbacher JW, Takkenberg JJ: Performance of the Cryo-Valve SG human decellularized pulmonary valve in 342 patients relative to the conventional CryoValve at a mean follow-up of four years. J Thorac Cardiovasc Surg 2010; 139: 339-348.
51. Konuma T, Devaney EJ, Bove EL, Gelehrter S, Hirsch JC, Tavakkol Z, Ohye RG: Performance of CryoValve SG decellularized pulmonary allografts compared with standard cryopreserved allografts. Ann Thorac Surg 2009; 88:849-854.
52. Sayk F, Bos I, Schubert U, Wedel T, Sievers HH: Histopathologic findings in a novel de-cellularized pulmonary homograft: an autopsy study. Ann Thorac Surg 2005; 79: 1755-1758.
53. Simon P, Kasimir MT, Seebacher G, Weigel G, Ullrich R, Salzer-Muhar U, Rieder E, Wolner E: Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J Cardiothorac Surg 2003; 23: 1002-1006.
54. Kasimir MT, Rieder E, Seebacher G, Nigisch A, Dekan B, Wolner E, Weigel G, Simon P: Decellularization does not eliminate throm-bogenicity and inflammatory stimulation in tissue-engineered porcine heart valves. J Heart Valve Dis 2006; 15:278-286.
55. Lopes SA, Costa FD, Paula JB, Dhomen P, Phol F, Vilani R, Roderjan JG, Vieira ED: Decellularized heterografts versus cryopre-served homografts: experimental study in sheep model. Rev Bras Cir Cardiovasc 2009; 24:15-22.
56. da Costa FD, Costa AC, Prestes R, Domanski AC, Balbi EM, Ferreira AD, Lopes SV: The early and midterm function of decellular-ized aortic valve allografts. Ann Thorac Surg 2010; 90:1854-1860.
57. Erdbrügger W, Konertz W, Dohmen PM, Posner S, Ellerbrok H, Brodde OE, Robenek H, Modersohn D, Pruss A, Holinski S, Stein-Konertz M, Pauli G: Decellularized xeno-genic heart valves reveal remodeling and growth potential in vivo. Tissue Eng 2006; 12:2059-2068.
58. Pörtner R, Nagel-Heyer S, Goepfert C, Ada-mietz P, Meenen NM: Bioreactor design for tissue engineering, J Biosci Bioeng 2005; 100: 235-245
59. Tan PH, Chan C, Xue SA, Dong R, Ananthe-sayanan B, Manunta M, Kerouedan C, Cheshire NJ, Wolfe JH, Haskard DO, Taylor KM, George AJ: Phenotypic and functional differences between human saphenous vein (HSVEC) and umbilical vein (HUVEC) en-dothelial cells. Atherosclerosis 2004; 173: 171-183.
60. Lichtenberg A, Tudorache I, Cebotari S, Su-prunov M, Tudorache G, Goerler H, Park JK, Hilfiker-Kleiner D, Ringes-Lichtenberg S, Ka rck M, Brandes G, Hilfiker A, Haverich A: Preclinical testing of tissue-engineered heart valves re-endothelialized under simulated physiological conditions. Circulation 2006; 114:I559-I565.
61. Akhyari P, Kamiya H, Gwanmesia P, Aubin H, Tschierschke R, Hoffmann S, Karck M, Lichtenberg A: In vivo functional performance and structural maturation of decel-lularised allogenic aortic valves in the sub-coronary position. Eur J Cardiothorac Surg 2010; 38: 539-546.
62. Guldner NW, Jasmund I, Zimmermann H, Heinlein M, Girndt B, Meier V, Flüss F, Ro-hde D, Gebert A, Sievers HH: Detoxification and endothelialization of glutaraldehyde-fixed bovine pericardium with titanium coating: a new technology for cardiovascular tissue engineering. Circulation 2009; 119: 1653-1660.
63. Lovett M, Lee K, Edwards A, Kaplan DL: Vascularization strategies for tissue engineering. Tissue Eng Part B Rev 2009; 15: 353-370.
64. Badylak SF, Kochupura PV, Cohen IS, Doro-nin SV, Saltman AE, Gilbert TW, Kelly DJ, Ignotz RA, Gaudette GR: The use of extracellular matrix as an inductive scaffold for the partial replacement of functional myocardium. Cell Transplant 2006; 15:S29-S40.
65. Chang Y, Lee MH, Liang HC, Hsu CK, Sung HW: Acellular bovine pericardia with distinct porous structures fixed with genipin as an extracellular matrix. Tissue Eng 2004; 10: 881-892.
66. Ota T, Gilbert TW, Schwartzman D, McTier-nan CF, Kitajima T, Ito Y, Sawa Y, Badylak SF, Zenati MA: A fusion protein of hepatocyte growth factor enhances reconstruction of myocardium in a cardiac patch derived from porcine urinary bladder matrix. J Thorac Ca rdiovasc Surg 2008; 136: 1309-1317.
67. Chang Y, Lai PH, Wei HJ, Lin WW, Chen CH, Hwang SM, Chen SC, Sung HW: Tissue regeneration observed in a basic fibroblast growth factor-loaded porous acellular bovine pericardium populated with mesenchy-mal stem cells. J Thorac Cardiovasc Surg 2007; 134: 65-73.
68. Gaebel R, Ma N, Liu J, Guan J, Koch L, Klopsch C, Gruene M, Toelk A, Wang W, Mark P, Wang F, Chichkov B, Li W, Steinhoff G: Patterning human stem cells and endo-thelial cells with laser printing for cardiac regeneration. Biomaterials 2011; 32:9218-9230.
69. Tudorache I, Kostin S, Meyer T, Teebken O, Bara C, Hilfiker A, Haverich A, Cebotari S: Viable vascularized autologous patch for transmural myocardial reconstruction. Eur J Cardiothorac Surg 2009; 36: 306-311.
70. Ruel MA, Sellke FW, Bianchi C, Khan TA, Faro R, Zhang JP, Cohn WE: Endogenous myocardial angiogenesis and revasculariza-tion using a gastric submucosal patch. Ann Thorac Surg 2003; 75: 1443-1449.
71. Huang W, Zhang D, Millard RW, Wang T, Zhao T, Fan GC, Ashraf A, Xu M, Ashraf M, Wang Y: Gene manipulated peritoneal cell patch repairs infarcted myocardium. J Mol Cell Cardiol 2010; 48:702-712.
72. Acker MA, Hammond RL, Mannion JD, Salmons S, Stephenson LW: Skeletal muscle as the potential power source for a cardiovascular pump: assessment in vivo. Science 1987; 236:324-327.
73. Menasché P: Skeletal myoblasts as a therapeutic agent. Prog Cardiovasc Dis 2007; 50: 7-17.
74. Taheri SA, Ashraf H, Merhige M, Miletich RS, Satchidanand S, Malik C, Naughton J, Zhao Q: Myoangiogenesis after cell patch cardiomyoplasty and omentopexy in a patient with ischemic cardiomyopathy. Tex Hear t Inst J 2005; 32: 598-601.
75. Wang B, Borazjani A, Tahai M, Curry AL, Simionescu DT, Guan J, To F, Elder SH, Liao J: Fabrication of cardiac patch with decellu-larized porcine myocardial scaffold and bone marrow mononuclear cells. J Biomed Mater Res A 2010; 94: 1100-1110.
76. Yildirim Y, Naito H, Didié M, Karikkineth BC, Biermann D, Eschenhagen T, Zimmer-mann WH: Development of a biological ventricular assist device: preliminary data from a small animal model. Circulation 2007; 116:I16-I23.
77. Zimmermann WH, Melnychenko I, Was-meier G, Didié M, Naito H, Nixdorff U, Hess A, Budinsky L, Brune K, Michaelis B, Dhein S, Schwoerer A, Ehmke H, Eschenhagen T: Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med 2006; 12:452-458.